Tioconazole is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As Tioconazole has been shown to be effective only for candidal vulvovaginitis,the diagnosis should be confirmed by KOH smears and/or cultures. Other pathogens commonly associated with vulvovaginitis should be ruled out by appropriate methods
Tioconazole is a topical antifungal agent. It is a broad-spectrum antifungal agent that inhibits the growth of human pathogenic yeasts. It exhibits fungicidal activity in-vitro against Candida albicans, other species of the genus Candida and against Torulopsis glabrata.
Topical: Apply & massage gently into the affected & surrounding skin area once or twice a day. In intertriginous areas,apply sparingly & smoothed in well to avoid macerating effects. Duration: 1-6 weeks. Vaginal candidiasis: Adult: As 6.5% ointment: Admin intravaginally at bedtime as a single dose. Child: ?12 yr Admin at bedtime as a single dose.
Hypersensitivity to Cyclosporine or to any of the excipients of Cyclosporine.
sensitive to imidazole antifungal agents or to other components of the ointment.
local transient & mild irritation
there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Acute overdosage with topical application of clotrimazole is unlikely and would not be expected to lead to a life-threatening situation
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
.png&w=384&q=75)